Literature DB >> 11474791

Characterization of two polymorphs of salmeterol xinafoate crystallized from supercritical fluids.

H H Tong1, B Y Shekunov, P York, A H Chow.   

Abstract

PURPOSE: To characterize two polymorphs of salmeterol xinafoate (SX-I and SX-II) produced by supercritical fluid crystallization.
METHODS: SX-I and SX-II were crystallized as fine powders using Solution Enhanced Dispersion by Supercritical Fluids (SEDS). The two polymorphs and a reference micronized SX sample (MSX) were characterized using powder X-ray diffractometry (PXRD), Fourier transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), aqueous solubility (and dissolution) determination at 5-40 degrees C, BET adsorption analysis, and inverse gas chromatography (IGC).
RESULTS: Compared with SX-I, SX-II exhibited a lower enthalpy of fusion, a higher equilibrium solubility, a higher intrinsic dissolution rate, a lower enthalpy of solution (based on van't Hoff solubility plots), and a different FTIR spectrum (reflecting differences in intermolecular hydrogen bonding). Solubility ratio plot yielded a transition temperature (-99 degrees C) below the melting points of both polymorphs. MSX showed essentially the same crystal form as SX-I (confirmed by PXRD and FTIR), but a distinctly different thermal behaviour. Mild trituration of SX-I afforded a similar DSC profile to MSX while prolonged grinding of SX-I gave rise to an endotherm at -109 degrees C, corresponding to solid-solid transition of SX-I to SX-II. Surface analysis of MSX, SX-I, and SX-II by IGC revealed significant differences in surface free energy in terms of both dispersive (nonpolar) interactions and specific (polar) acid-base properties.
CONCLUSIONS: The SEDS-processed SX-I and SX-II display high polymorphic purity and distinctly different physical and surface properties. The polymorphs are related enantiotropically with SX-I being the thermodynamically stable form at room temperature.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11474791     DOI: 10.1023/a:1011000915769

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  2 in total

Review 1.  Phase behavioral effects on particle formation processes using supercritical fluids.

Authors:  S Palakodaty; P York
Journal:  Pharm Res       Date:  1999-07       Impact factor: 4.200

2.  Determination of salmeterol in metered-dose and dry-powder inhalers by reversed-phase high performance liquid chromatography.

Authors:  V G Nayak; S G Belapure; C D Gaitonde; A A Sule
Journal:  J Pharm Biomed Anal       Date:  1996-02       Impact factor: 3.935

  2 in total
  7 in total

1.  Use of inverse gas chromatography (IGC) to determine the surface energy and surface area of powdered materials.

Authors:  A H L Chow; H H Y Tong; B Y Shekunov; P York
Journal:  Pharm Res       Date:  2004-09       Impact factor: 4.200

Review 2.  Particle engineering for pulmonary drug delivery.

Authors:  Albert H L Chow; Henry H Y Tong; Pratibhash Chattopadhyay; Boris Y Shekunov
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

3.  Thermal analysis of trace levels of polymorphic impurity in salmeterol xinafoate samples.

Authors:  Henry H Y Tong; Boris Yu Shekunov; Peter York; Albert H L Chow
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

4.  Effect of processing route on the surface properties of amorphous indomethacin measured by inverse gas chromatography.

Authors:  D J Burnett; J Khoo; M Naderi; J Y Y Heng; G D Wang; F Thielmann
Journal:  AAPS PharmSciTech       Date:  2012-11-08       Impact factor: 3.246

5.  Influence of polymorphism on the surface energetics of salmeterol xinafoate crystallized from supercritical fluids.

Authors:  Henry H Y Tong; Boris Yu Shekunov; Peter York; Albert H L Chow
Journal:  Pharm Res       Date:  2002-05       Impact factor: 4.200

6.  Evidence for the existence of powder sub-populations in micronized materials: aerodynamic size-fractions of aerosolized powders possess distinct physicochemical properties.

Authors:  Sara Jaffari; Ben Forbes; Elizabeth Collins; Jiyi Khoo; Gary P Martin; Darragh Murnane
Journal:  Pharm Res       Date:  2014-12       Impact factor: 4.200

7.  Microencapsulation of Fluticasone Propionate and Salmeterol Xinafoate in Modified Chitosan Microparticles for Release Optimization.

Authors:  Nina Maria Ainali; Eleftheria Xanthopoulou; Georgia Michailidou; Alexandra Zamboulis; Dimitrios N Bikiaris
Journal:  Molecules       Date:  2020-08-26       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.